Alcon Return on Tangible Equity 2019-2025 | ALC
Current and historical return on tangible equity values for Alcon (ALC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Alcon Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $1.12B | $3.46B | 30.96% |
| 2024-12-31 | $1.02B | $4.02B | 29.11% |
| 2024-09-30 | $1.16B | $3.73B | 36.84% |
| 2024-06-30 | $1.10B | $3.26B | 40.49% |
| 2024-03-31 | $1.05B | $2.98B | 45.40% |
| 2023-12-31 | $0.97B | $2.64B | 51.10% |
| 2023-09-30 | $0.45B | $2.02B | 29.76% |
| 2023-06-30 | $0.36B | $1.60B | 23.97% |
| 2023-03-31 | $0.34B | $1.37B | 21.77% |
| 2022-12-31 | $0.34B | $1.06B | 20.74% |
| 2022-09-30 | $0.57B | $2.01B | 32.70% |
| 2022-06-30 | $0.46B | $1.83B | 29.16% |
| 2022-03-31 | $0.46B | $1.57B | 33.97% |
| 2021-12-31 | $0.38B | $1.59B | 30.50% |
| 2021-09-30 | $0.33B | $1.29B | 31.88% |
| 2021-06-30 | $0.18B | $0.97B | 22.60% |
| 2021-03-31 | $-0.39B | $1.08B | -63.83% |
| 2020-12-31 | $-0.53B | $0.82B | -127.41% |
| 2020-09-30 | $-0.72B | $0.37B | -282.84% |
| 2020-06-30 | $-0.64B | $0.18B | -391.99% |
| 2020-03-31 | $-0.60B | $0.30B | -808.03% |
| 2019-12-31 | $-0.66B | $0.17B | 52480.00% |
| 2019-06-30 | $-0.71B | $-0.17B | 1641.86% |
| 2019-03-31 | $-0.30B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.070B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.102B | 81.07 |
| Thermo Fisher Scientific (TMO) | United States | $160.563B | 19.42 |
| Edwards Lifesciences (EW) | United States | $45.919B | 30.11 |
| IDEXX Laboratories (IDXX) | United States | $42.738B | 49.12 |
| DexCom (DXCM) | United States | $33.459B | 51.72 |
| IQVIA Holdings (IQV) | United States | $27.702B | 15.52 |
| Mettler-Toledo (MTD) | United States | $24.812B | 29.51 |
| STERIS (STE) | Ireland | $22.211B | 24.46 |
| Waters (WAT) | United States | $18.101B | 25.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.184B | 0.00 |
| Hologic (HOLX) | United States | $14.400B | 15.65 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $9.268B | 72.74 |
| Masimo (MASI) | United States | $8.767B | 32.34 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.953B | 0.00 |
| Teleflex (TFX) | United States | $5.115B | 8.44 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| TransMedics (TMDX) | United States | $3.953B | 85.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.218B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.099B | 24.07 |
| Veracyte (VCYT) | United States | $2.087B | 29.29 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.595B | 0.00 |
| Artivion (AORT) | United States | $1.353B | 126.72 |
| Pulse Biosciences (PLSE) | United States | $1.081B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.738B | 37.47 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.619B | 13.42 |
| Beta Bionics (BBNX) | United States | $0.556B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| AxoGen (AXGN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 10.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.413B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.391B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| RxSight (RXST) | United States | $0.315B | 0.00 |
| NeuroPace (NPCE) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.209B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.20 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |